'Hypertension' and 'microalbuminuria': the bell tolls for thee

J P Forman1, B M Brenner

  • 1Harvard Medical School, Boston, Massachusetts, USA. jforman@partners.org

Kidney International
|December 24, 2005
PubMed

Insights

The continuous relationship between blood pressure, albumin excretion, and cardiovascular disease suggests current diagnostic terms like hypertension and microalbuminuria are inadequate. Lowering these markers reduces cardiovascular risk, challenging established

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Public Health

Background:

  • Numerous studies demonstrate a continuous relationship between blood pressure, albumin excretion, and cardiovascular disease risk.
  • Lower blood pressure (e.g., 115/75 mmHg) and albumin excretion (e.g., <2 mg/day) are associated with reduced cardiovascular risk.
  • Modern lifestyle factors may have shifted 'normal' physiological values, creating 'neo-normal' standards.

Purpose of the Study:

  • To challenge the dichotomous definitions of hypertension and microalbuminuria.
  • To propose alternative terminology reflecting the continuous nature of disease risk.
  • To advocate for a re-evaluation of 'normal' physiological standards in light of evolutionary and modern lifestyle factors.

Main Methods:

  • Review of existing epidemiological and clinical data on blood pressure, albuminuria, and cardiovascular outcomes.
  • Comparative analysis of physiological norms across different populations and lifestyles.
  • Hypothesis generation based on evolutionary mismatch between Paleolithic genotype and modern environment.

Main Results:

  • Data support a continuous, graded association between blood pressure, albumin excretion, and cardiovascular risk, rather than distinct thresholds.
  • Current 'normal' ranges for blood pressure and albuminuria may not reflect optimal cardiovascular health.
  • The terms 'hypertension' and 'microalbuminuria' may oversimplify complex risk relationships.

Conclusions:

  • The medical community should consider abandoning the terms 'hypertension' and 'microalbuminuria'.
  • Alternative terms like 'blood pressure-associated disease' and 'albuminuria-associated disease' are proposed.
  • Revising diagnostic standards is crucial for accurate cardiovascular risk assessment and management.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...